Tumor-derived VEGF is one of these negative factors and is responsible for the differentiation of hematopoietic progenitor cells to DCs, which inhibits the phosphorylation and corresponding degradation of IκB, resulting in the attenuation of NF-κB activation in immature DCs [67,68]. The gene discussed is VEGFA; the disease is neoplasm.